Humana, Clover Soar On Medicare Advantage Star Rating; These Stocks Sink
Humana and Clover shares rallied following the release of the 2027 Medicare Advantage star ratings by the Centers for Medicare and Medicaid Services. Humana announced that 95% of its Medicare Advantage members will be in 4-star plans or higher for 2027. Meanwhile, other major health insurers including UnitedHealth, Aetna, and HCSC experienced slips in their ratings, while Alignment Healthcare plummeted in the new evaluations. The star ratings are critical for insurers as they help determine bonus payments and shape the competitive positioning of healthcare stocks.
Listen to Live Briefing
Real-time synthesized voice briefing Β· Live Feeds Desk
- β Humana announced that 95% of its Medicare Advantage members will be in 4-star plans for 2027.
- β About 71% of Medicare Advantage prescription drug plan enrollees are in coverage with four or more stars for 2027, according to the Centers for Medicare and Medicaid Services.
- β Humana shares gained more than 11% on October 9 after analysts named it a major potential beneficiary of the new ratings.
What changed
The Centers for Medicare and Medicaid Services released the 2027 Medicare Advantage star ratings, driving sharp stock gains for Humana and Clover alongside declines for competitors like Alignment Healthcare.
Live updates
-
Humana, Clover Soar On Medicare Advantage Star Ratings
Humana and Clover shares rallied following the release of the 2027 Medicare Advantage star ratings by the Centers for Medicare and Medicaid Services. Humana announced that 95% of its Medicare Advantage members will be in 4-star plans or higher for 2027. Meanwhile, other major health insurers including UnitedHealth, Aetna, and HCSC experienced slips in their ratings, while Alignment Healthcare plummeted in the new evaluations. The star ratings are critical for insurers as they help determine bonus payments and shape the competitive positioning of healthcare stocks.
Why it matters
The annual quality ratings released by the Centers for Medicare and Medicaid Services directly influence insurer bonus structures and plan enrollments for upcoming coverage years. Variations in these scores frequently trigger sharp market reactions, rewarding providers who secure higher quality tiers while penalizing those that slip. Across the broader market, roughly 71% of Medicare Advantage prescription drug plan enrollees are in coverage with four or more stars for 2027.
What is confirmed
- Humana announced that 95% of its Medicare Advantage members will be in 4-star plans for 2027.
- About 71% of Medicare Advantage prescription drug plan enrollees are in coverage with four or more stars for 2027, according to the Centers for Medicare and Medicaid Services.
- Humana shares gained more than 11% on October 9 after analysts named it a major potential beneficiary of the new ratings.
What to watch next
- Monitor how revised star ratings impact actual financial earnings and bonus payouts for insurers.
- Track enrollment figures for 2027 Medicare Advantage plans as open enrollment proceeds.
confidence 100%Sources used for this update (20)
- www.humana.com β Humana | Find Medicare Plans and Health Insurance Coverage
- WSJ β Humana Says 95% of Medicare Advantage Members in 4-Star Plans for 2027
- Fierce Healthcare β CMS: About 71% of MAPD plan enrollees in coverage with four or more stars for 2027
- Healthcare Dive β Humana soars, Alignment plummets in 2027 Medicare Advantage star ratings
- Yahoo Finance β HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses
- Bloomberg.com β Humana Surges on Medicare Quality Ratings Improvement
- Modern Healthcare β UnitedHealth, Aetna, HCSC star ratings slip
- Reuters β Most Medicare Advantage drug plan enrollees in high-quality plans, US government says
- CNBC β Humana surges after topping 2027 Medicare star ratings
- Barron's β Humana Stock Surges After Key Medicare Advantage Plan Gets Higher Rating
- Investor's Business Daily β Humana, Clover Soar On Medicare Advantage Star Rating; These Stocks Sink
- Yahoo Finance β Seniors Face an 18% Drop in Highly Rated Medicare Advantage Plans β But Quality Might Not Be the Cause
Community Sentiment: How do you assess this situation?
Voice your perspective Β· Real-time aggregated sentiment from the Live Feeds community